Green Tea Compound EGCG Inhibits Hepatitis C Virus

Hepatitis C virus infection can result in cirrhosis, chronic hepatitis, and primary liver cancer or hepatocellular carcinoma. Hepatitis C virus is a common reason for chronic liver disease as well as a primary indicator for liver transplantation, impacting up to 170 million people around the world based on WHO estimates. Earlier research reports that almost 2% of the world’s population have chronic hepatitis C virus and as much as 20% of the population is infected in certain countries.

Though standard treatment with ribavirin and interferon, as well as newer protease inhibitors might clear infection in certain people, a considerable amount of individuals still don’t respond to these treatments. For people receiving liver transplants as a result of hepatitis C virus complications, re-infection of the healthy donor liver is still a major problem. Antiviral strategies are urgently needed which target hepatitis C virus in its initial phases for preventing graft re-infection and improving long term outcomes for sufferers.

A study researched the effect of the main component of green tea, the EGCG molecule, in the prevention of the hepatitis C virus from attaching to the liver cells. Catechins like EGCG and its derivatives EC (epicatechin), ECG (epicatechingallate), and EGC (epigallocatechin) have been shown to have anti-oncogenic and antiviral properties. The potential these flavonoids have in the prevention of hepatitis C virus re-infection after liver transplantation was also explored in the study.[1]

Unlike its derivatives, the study results demonstrated that EGCG inhibits entry of hepatitis C virus into liver cells. The researchers suggest that the hepatitis C virus cell entry was impeded by EGCG acting on the host cell since the green tea catechin wasn’t found to alter the virus particles density. Pre-treatment of cells with EGCG before hepatitis C virus inoculation didn’t reduce the infection; however the rapid spread of the hepatitis C virus was inhibited by application during inoculation. Finally, the study revealed that EGCG inhibits viral attachment, step one in the hepatitis C virus infection process. EGCG inhibits hepatitis C virus cell entry by preventing viral attachment and could present a new approach for preventing hepatitis C virus infection, in particular re-infection after liver transplantation.

Hepatitis C Infographic

Save

Want to use any of our images on your site?
Just right click on image for the embed code
Want more articles like this?

Get your daily dose of health by subscribing to our newsletter

Please wait...
Your information will never be shared with any third party. You can unsubscribe anytime.

Thank you for signing up!

close

Simply copy and paste the code below to embed the image on your page